What You Should Know:
- A new analysis from Vizient® reveals the staggering financial impact of drug shortages on U.S. hospitals, with labor costs for managing these disruptions more than doubling since 2019.
- The survey, "Beyond the Shortage: The Hidden Cost of Drug Supply Chain Disruptions," found that in 2023, hospitals spent roughly 20 million hours managing drug shortages, translating to nearly $900 million annually in labor costs.
The Hidden Costs Go Far Beyond
Read More
PwC: Health Services M&A Remains Durable Despite Headwinds
What You Should Know:
- Health services M&A activity has demonstrated remarkable durability, weathering a complicated macroeconomic and political environment to remain well ahead of pre-COVID levels, according to PwC’s US Deals 2025 Mid-Year Outlook for both Health Services and Pharmaceutical and Life Sciences.
- Through May 15, 2025, the market saw 445 announced transactions, bringing the last-twelve-month (LTM) total to 1,265 deals with a disclosed value of approximately
Read More
European Digital Health Startups Face ‘Existential Risk’ Amid Funding Pullback and ROI Demands, New Report Finds
What You Should Know:
- A new report from Black Book Research reveals significant headwinds facing the European digital health sector, with a survey of 54 early-stage startups highlighting investor pullback, cross-border scalability challenges, and increasing demands from health systems for evidence-based ROI.
- The findings paint a picture of a market in a "precarious holding pattern," where many innovative companies are struggling to survive.
Pandemic-Era Winners Now
Read More
Caris Life Sciences Announces Pricing of Initial Public Offering
What You Should Know:
- Caris Life Sciences® (Caris), an AI TechBio company and pioneer in precision medicine, today announced the pricing of its initial public offering (IPO) of 23,529,412 shares of its common stock at a public offering price of $21.00 per share.
- The shares are expected to begin trading on the Nasdaq Global Select Market on June 18, 2025, under the ticker symbol “CAI.” The offering is expected to close on June 20, 2025, subject to customary closing
Read More
Nabla Raises $70M to Build an “Agentic” AI Assistant for Clinicians
What You Should Know:
- Nabla, one of the most widely adopted AI assistants in clinical care secures $70M in Series C funding led by HV Capital, with Highland Europe joining as a key investor, alongside DST Global, and existing investors Cathay Innovation, and Tony Fadell’s Build Collective. The funding brings Nabla’s total capital raised to $120M.
- The new capital will accelerate product development, fuel growth across Nabla’s technical and go-to-market teams, and support strategic
Read More
Sword Health Raises $40M, Launches AI-Powered Mental Health Solution “Mind”
What You Should Know:
- Sword Health, the world’s leading AI Care company raises $40M funding round at a $4B valuation, led by General Catalyst.
- The company also unveiled Mind, a revolutionary mental health solution that combines AI and licensed clinicians to deliver continuous, personalized care, aiming to transform mental health from episodic talk therapy to a proactive, always-on support system.
- The new funding will accelerate the evolution of Sword's AI Care model,
Read More
HOPPR Secures $31.5M to Scale its AI Medical Imaging Development Platform
What You Should Know:
- HOPPR, the company revolutionizing how AI imaging applications are built, validated, and deployed secures $31.5M in an oversubscribed Series A funding round led by Kivu and Greycroft, with participation from PSG Equity, Morningside Capital, Fortitude Ventures, and existing investor Health 2047.
- HOPPR intends to accelerate platform development, scale operations, expand its foundation model capabilities, and grow its team of top-tier talent.
Addressing a
Read More
Quilt Health Raises $6M to Modernize Clinical Trial Access for Complex Diseases
What You Should Know:
- Quilt Health, a digital health company dedicated to bridging gaps in treatment access for complex diseases secures $6M in seed funding round, bringing its total funding to $8M. The round was led by MaC Venture Capital and Underscore Ventures, with participation from Meridian Street Capital, BoxGroup, Watershed VC, and Coalition Operators.
- Founded with an initial focus on sickle cell disease, the company plans to use the new capital to rapidly expand into
Read More
INSIGHTS: What Leaders Expect to Hear at HFMA Annual Conference
As healthcare finance leaders prepare to gather for the upcoming HFMA Annual Conference, they face a familiar but intensified set of challenges: shrinking margins, rising operational costs, and an increasingly complex reimbursement landscape. This year, however, a dominant theme emerges from the conversation: the role of Artificial Intelligence in revolutionizing the revenue cycle. We asked six healthcare executives for insights on what key themes/trends they expect to be the most talked
Read More
Capital Rx to Acquire Healthcare Navigation Platform Amino Health
What You Should Know:
- Capital Rx, Inc., the enterprise health technology company announced the acquisition of Amino Health and its comprehensive health navigation platform. Amino Health will now become Capital Rx’s care navigation solution, named Judi Care, significantly extending the company’s enterprise platform capabilities to nearly 60 million covered lives.
- The strategic acquisition allows Capital Rx to offer employers all the necessary components to create a holistic
Read More
